Atrial fibrillation
Conditions
Interventions
Multi-level intervention group:Level 1 Function - Village Doctors: Assist in atrial fibrillation detection, patient registration, atrial fibrillation clinic, and follow-up notifications
Level 2 Function - Township Hospital Doctors: Establish personalized atrial fibrillation records, conduct off-site supervision and intervention for patients and first-degree relatives, and implement r
Level 3 Function: Digital video-based patient education, training to enhance primary healthcare providers' atrial fibrillation management capabilities, and diagnostic and treatment support for complex
Routine care group:First-level functions: (1) Information registration: includes basic public health information of participants
(2) Encourages atrial fibrillation patients aged 65 and above within the jurisdiction to attend annual primary public health check-ups on time
Second-level functions: Standardized in-hospital atrial fibrillation management led by internal medicine physicians and chronic disease management teams at district hospitals: (1) Standardized outpati
(2) Implementation of standardized in-hospital diagnosis and treatment
(3) Pre-discharge instructions
(4) Participation in capacity-building training provided by higher-level guidance hospitals.
Sponsors
The Third People's Hospital of Chengdu
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: 1) Permanent residents of the pilot villages who are over 65 years old and regularly participate in the government-organized rural public health physical examination program annually; 2) Have a confirmed diagnosis of atrial fibrillation through 12-lead ECG/Holter/cardiology specialist/hospital referral pathway; 3) Have at least one eligible first-degree relative living in the same area (within the Eastern New Area of Chengdu) during the trial period, and the first-degree relative agrees to participate in the study; 4) Capable of self-care in daily life; 5) Able to communicate via telephone.
Exclusion criteria
Exclusion criteria: 1) Patients with moderate to severe mitral stenosis or those who have undergone heart valve replacement surgery; 2) Patients with a history of ICD or CRT device implantation; 3) Patients who underwent radiofrequency ablation or cardiac surgery within 3 months prior to enrollment; 4) Patients with a history of pulmonary vein isolation or left atrial appendage occlusion; 5) Patients with contraindications to anticoagulation; 6) Patients with an expected survival time of less than 1 year; 7) Patients participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anticoagulation compliance rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| AFEQT score;EHRA score;PROMIS-29 system;Number of emergency room visits due to atrial fibrillation episodes;Number of hospitalizations due to atrial fibrillation episodes;Length of hospital stay due to atrial fibrillation episode;Major bleeding events; | — |
Countries
China
Contacts
Public ContactZhang Zhen
The third people's hospital of Chengdu
Outcome results
None listed